BK vs CODX · P/E 17, rev $20.08B vs rev $3.9M
The Bank of New York Mellon Corporation (BK) versus Co-Diagnostics, Inc. Common Stock (CODX) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Latest reported BK revenue for 2025-12-31 was $20.08B. Net income was $5.55B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. BK currently screens at market cap $94.14B and trailing P/E 17.0.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
BK currently screens at market cap $94.14B and trailing P/E 17.0. CODX currently screens at market cap $31.4M.
Not investment advice. Open the BK and CODX stock pages for the full models.
Not investment advice.